Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02067260 · ClinicalTrials.gov registry record · NA

A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males

A NA study of Androgenetic Alopecia, sponsored by Spencer Forrest.

Completed
Registry status
NA
Development phase
3
Study locations

NCT02067260 is a NA study of Androgenetic Alopecia that has completed, run by Spencer Forrest. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02067260, a NA study of Androgenetic Alopecia, has completed, sponsored by Spencer Forrest.

COMPLETED
Registry status
NA
Development phase
3
Study locations

Study Summary

The overall purpose of this clinical investigation is to collect data to support a marketing application for over the counter use of the X5 HairLaser with an indication for hair growth. The goal of this protocol is to demonstrate that the intended users of the X5 HairLaser can safely and effectively perform self-use application by following written instructions.

Conditions Studied

Androgenetic Alopecia

Interventions

  • DEVICE X5 HairLaser
  • DEVICE X5 Hair Laser Sham Device

Study Locations (3)

Arkansas

  • Burke Pharmaceutical Research - Hot Springs

Florida

  • Hilltop Research - St. Petersburg

New York

  • NYU School of Medicine - New York

Trial Details

FieldValue
Phase NA

Sponsor

Spencer Forrest

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02067260

The ClinicalTrials.gov registry entry for NCT02067260 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Spencer Forrest, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Androgenetic Alopecia appearing as the primary indexed condition, and to 2 interventions - of which X5 HairLaser is the first listed.

NCT02067260 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arkansas, Florida, New York.

Frequently Asked Questions

What is clinical trial NCT02067260 about?

NCT02067260 is a clinical study titled "A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males". The overall purpose of this clinical investigation is to collect data to support a marketing application for over the counter use of the X5 HairLaser with an indication for hair growth. The goal of this protocol is to demonstrate that the intended users of the X5 HairLaser can safely and effectively...

What is the current status of trial NCT02067260?

This trial is currently completed. It is a NA study.

What conditions does trial NCT02067260 study?

This clinical trial studies the following conditions: Androgenetic Alopecia.

What interventions are being tested in trial NCT02067260?

The interventions under investigation include: X5 HairLaser (DEVICE), X5 Hair Laser Sham Device (DEVICE).

Who is sponsoring clinical trial NCT02067260?

This trial is sponsored by Spencer Forrest, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02067260 being conducted?

This trial has 3 study locations across Arkansas, Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Androgenetic Alopecia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Androgenetic Alopecia

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.